Detalhe da pesquisa
1.
Modulation of Neutrophil Function by Recombinant Human IgG1 Fc Hexamer in the Endogenous K/BxN Mouse Model of Rheumatoid Arthritis.
Pharmacology
; 108(2): 176-187, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696888
2.
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.
J Immunol
; 200(8): 2542-2553, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531170
3.
Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-µTP-L309C, a recombinant IgG1 Fc hexamer.
BMC Immunol
; 20(1): 44, 2019 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801459
4.
Effects of C1 inhibitor on endothelial cell activation in a rat hind limb ischemia-reperfusion injury model.
J Vasc Surg
; 68(6S): 209S-221S.e2, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29395422
5.
Effect of intravenous IgG therapy on natural killer cell function related to Fc gamma receptor gene expression.
J Allergy Clin Immunol
; 146(3): 667-670, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32311389
6.
IgG hexamers initiate acute lung injury.
bioRxiv
; 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328049
7.
IgG hexamers initiate complement-dependent acute lung injury.
J Clin Invest
; 134(11)2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530369
8.
Mechanism of increased efficacy of recombinant Fc-µTP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia.
EJHaem
; 2(4): 789-793, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35845218
9.
The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells.
J Immunol
; 181(2): 878-90, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18606639
10.
Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation.
Mol Immunol
; 45(16): 4084-94, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18722664
11.
Next-generation Fc receptor-targeting biologics for autoimmune diseases.
Autoimmun Rev
; 18(10): 102366, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31404703
12.
Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro.
Front Immunol
; 10: 556, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972058
13.
Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
Neuropharmacology
; 133: 345-353, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29428821
14.
Flow cytometric analysis on cross-reactivity of human-specific CD monoclonal antibodies with splenocytes of Aotus nancymaae, a non-human primate model for biomedical research.
Vet Immunol Immunopathol
; 119(1-2): 14-20, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17644187
15.
IVIG in autoimmune disease - Potential next generation biologics.
Autoimmun Rev
; 15(8): 781-5, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27019051
16.
Reconstituted high-density lipoprotein modulates activation of human leukocytes.
PLoS One
; 8(8): e71235, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23967171
17.
C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.
PLoS One
; 8(8): e72059, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991040
18.
The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.
Cardiol Res Pract
; 2012: 181394, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22577589
19.
Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate.
Mol Immunol
; 47(14): 2349-58, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20541808
20.
Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions.
PLoS One
; 5(6): e0010983, 2010 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20539755